The Food and Drug Administration declined to approve the biotechnology company's liver disease drug. Coty Inc., up 56 cents to $4.74. The owner of ...
News
- Coty, Boeing rise; Intercept Therapeutics, Heron fall
- Biopsy Devices Market to Eyewitness Massive Growth by 2026 | Boston University, Carlos III Health ...
... San Antonio, University of Twente, University of Washington, Vanderbilt University, Vascular BioSciences, Verisante Technology Inc, VitruMed Inc., ...
- Small fiber neuropathy can cause big woes
Several biotech companies are working on new drugs to treat all kinds of pain based on what has been learned from studying genetic mutations that ...
- Summer may decide fate of lead shots in virus vaccine race
Vaccines by Sinovac Biotech and SinoPharm use that old-fashioned technology, which requires high-security labs to produce but is dependable, the ...
- Children more resilient against coronavirus, study reveals
SAN ANTONIO – The majority of children with COVID-19 in 26 countries fared well clinically compared to adults during the first four months of the ...